Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0070
-0.00052 (-6.91%)
At close: Jun 16, 2026

Evofem Biosciences Earnings Call Transcripts

Fiscal Year 2025

  • Status Update

    Innovative women's health solutions are driving a strategic partnership focused on global impact and growth. Addressing a restrictive senior creditor is the key challenge before further capital and shareholder actions can proceed. Regular updates and mission-driven leadership underpin the outlook.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021